CorMedix Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CorMedix Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • CorMedix Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$3.29M, a 68.6% increase year-over-year.
  • CorMedix Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$51M, a 22.3% decline year-over-year.
  • CorMedix Inc. annual Operating Income (Loss) for 2023 was -$49M, a 59.9% decline from 2022.
  • CorMedix Inc. annual Operating Income (Loss) for 2022 was -$30.6M, a 4.03% decline from 2021.
  • CorMedix Inc. annual Operating Income (Loss) for 2021 was -$29.4M, a 8.14% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$51M -$3.29M +$7.18M +68.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$58.1M -$15.3M -$3.5M -29.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$54.6M -$16.7M -$5.69M -51.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$49M -$15.7M -$7.28M -86.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$41.7M -$10.5M -$3.51M -50.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 -$38.2M -$11.8M -$3.56M -43.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$34.6M -$11M -$3.98M -56.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$30.6M -$8.39M -$609K -7.83% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$30M -$6.96M +$1.6M +18.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$31.6M -$8.24M -$2.36M -40.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$29.3M -$7.03M +$178K +2.47% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$29.4M -$7.78M -$1.7M -27.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$27.7M -$8.56M -$1.96M -29.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$25.8M -$5.88M +$3.04M +34.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$28.8M -$7.21M -$1.6M -28.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$27.2M -$6.08M -$709K -13.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$26.5M -$6.6M -$1.43M -27.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$25.1M -$8.92M -$3.38M -61.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$21.7M -$5.61M -$689K -14% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$21M -$5.38M -$7.51M -351% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$13.5M -$5.17M +$5.07M +49.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$18.6M -$5.54M +$3.03M +35.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$21.6M -$4.92M +$5.27M +51.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$26.9M $2.14M +$12.4M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$39.3M -$10.2M -$2.23M -27.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$37M -$8.57M -$1.55M -22.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$35.5M -$10.2M -$2.57M -33.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$32.9M -$10.3M -$3.84M -59.8% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-05-29
Q3 2017 -$29.1M -$8.01M +$1.15M +12.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$30.2M -$7.02M -$2.11M -43% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$28.1M -$7.62M -$3.47M -83.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$24.6M -$6.43M -$6.43M Oct 1, 2016 Dec 31, 2016 10-K 2017-03-16
Q3 2016 -$18.2M -$9.16M -$9.15M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$9.07M -$4.91M -$4.91M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$4.16M -$4.15M -$4.14M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$16.7K -$3.89K* +$2.21M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$2.23M -$4.71K* +$1.86M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$4.09M -$4.14K* +$1.89M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$5.97M -$3.91K* +$2.93M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$8.9M -$2.21M -$650K -41.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$8.25M -$1.86M -$608K -48.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$7.64M -$1.89M -$601K -46.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$7.04M -$2.93M -$2.13M -264% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$4.92M -$1.56M -$1.07M -216% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$3.85M -$1.26M -$264K -26.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$3.58M -$1.29M -$675K -110% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$2.91M -$807K +$93.1K +10.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$3M -$495K -$380K -331% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$2.62M -$991K +$1.61M +61.9% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-03-04
Q2 2012 -$4.23M -$614K +$1.87M +75.3% Apr 1, 2012 Jun 30, 2012 10-Q/A 2014-03-04
Q1 2012 -$6.1M -$900K +$1.11M +55.2% Jan 1, 2012 Mar 31, 2012 10-Q/A 2014-03-04
Q4 2011 -$7.21M -$115K Oct 1, 2011 Dec 31, 2011 10-K/A 2014-03-04
Q3 2011 -$2.6M -$1.2M -85.5% Jul 1, 2011 Sep 30, 2011 10-Q/A 2013-03-27
Q2 2011 -$2.48M -$1.3M -110% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-06
Q1 2011 -$2.01M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$1.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$1.18M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.